MAF-1A derived peptide Mt6

General Information


DRACP ID  DRACP04438

Peptide Name   MAF-1A derived peptide Mt6

Sequence  KKFKKTAKWLIKSAWLLLKSLALKMK

Sequence Length  26

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C151H257N37O30S

Absent amino acids  CDEGHNPQRVY

Common amino acids  K

Mass  354911

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  13

Net charge  9

Boman Index  -946

Hydrophobicity  -6.92

Aliphatic Index  116.54

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  440

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36190276

Title  Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19890

DRACP is developed by Dr.Zheng's team.